Industry Focus

Bluebird bio, TG Therapeutics, and Loxo Oncology investors are smiling following bullish presentations for their respective cancer drugs at the annual American Society of Clinical Oncology conference this week.

Sponsored link: http://www.casper.com/fool code fool.

Direct download: IF06072017_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

1